Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
54 Leser
Artikel bewerten:
(0)

Fast Company Lists SOPHiA GENETICS in Prestigious's Top 10 Most Innovative Companies in Biotech for 2018

LAUSANNE, Switzerland, February 20, 2018 /PRNewswire/ --

SOPHiA GENETICS, global leader in Data-Driven Medicine, has been ranked 5th in Fast Company's Top 10 Most Innovative Companies in Biotech. The ranking recognizes companies that exemplify the best in business and innovation in their respective fields.

(Logo: https://mma.prnewswire.com/media/643891/Fast_Company_2018_Sophia_Genetics_Logo.jpg )

SOPHiA GENETICS' AI platform helps clinicians effectively diagnose and treat their patients. The company's Artificial Intelligence, SOPHiA, solves the complexity of genomic data analysis by accurately detecting disease-causing mutations in 5 disorders areas: hereditary cancer, oncology, cardiology, metabolism and pediatrics. To date, SOPHiA has been deployed across over 400 hospitals in 55 countries and has helped to better diagnose over 177'000 patients worldwide.

Fast Company's Top 10 lists recognize pioneering companies across 36 categories, from artificial intelligence to wellness. More than three dozen Fast Company editors, reporters, and contributors surveyed thousands of companies to create these lists.

ABOUT SOPHiA GENETICS

SOPHiA GENETICS: global leader in Data-Driven Medicine, SOPHiA GENETICS is a health tech company which has developed SOPHiA AI, the most advanced technology for clinical genomics, helping healthcare professionals better diagnose and treat patients. The global network of 410 institutions from 55 countries that use the SOPHiA DDManalytical platform powered by SOPHiA form the world's largest clinical genomics community. By enabling the rapid adoption of genomic testing worldwide, turning data into actionable clinical insights, and sharing knowledge through its community, SOPHiA GENETICS is democratizing Data-Driven Medicine to save lives equally. The company's achievements were recognized by MIT Technology Review who ranked it amongst the 50 Smartest Companies in 2017. More info: http://www.sophiagenetics.com

SOPHiA GENETICS is on Twitter, follow @SOPHiAGENETICS

ABOUT FAST COMPANY

Fast Company is the world's leading progressive business media brand, with a unique editorial focus on innovation in technology, ethical economics, leadership, and design. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, one of the U.S.'s leading media companies.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.